MedPath

山西诺成制药有限公司

Ownership
-
Established
2009-05-14
Employees
-
Market Cap
-
Website
www.sxnczy.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

66

NMPA:66

Drug Approvals

Cimetidine Injection

Product Name
西咪替丁注射液
Approval Number
国药准字H20253392
Approval Date
Feb 20, 2025
NMPA

红花注射液

Approval Number
国药准字Z14021814
Approval Date
Sep 19, 2023
NMPA

红花注射液

Approval Number
国药准字Z14021815
Approval Date
Sep 19, 2023
NMPA

Doxofylline Injection

Product Name
多索茶碱注射液
Approval Number
国药准字H20183188
Approval Date
Jun 14, 2023
NMPA

Pediatric Electrolyte Supplements Injection

Product Name
小儿电解质补给注射液
Approval Number
国药准字H20183026
Approval Date
Jan 18, 2023
NMPA

Pediatric Electrolyte Supplements Injection

Product Name
小儿电解质补给注射液
Approval Number
国药准字H20183027
Approval Date
Jan 18, 2023
NMPA

Sterile Water for Injection

Product Name
灭菌注射用水
Approval Number
国药准字H20173189
Approval Date
May 16, 2022
NMPA

Potassium Chloride Injection

Product Name
氯化钾注射液
Approval Number
国药准字H20173187
Approval Date
May 16, 2022
NMPA

Sterile Water for Injection

Product Name
灭菌注射用水
Approval Number
国药准字H20173188
Approval Date
May 16, 2022
NMPA

Fasudil Hydrochloride Injection

Product Name
盐酸法舒地尔注射液
Approval Number
国药准字H20213887
Approval Date
Nov 24, 2021
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.